Compare Keysight Technologies Inc (KEYS) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keysight Technologies Inc vs Stryker Corporation — how do they compare? Keysight Technologies Inc trades at $382.61 (market cap $63.79B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is the larger of the two by market cap, and Stryker Corporation pays a 1.27% dividend while Keysight Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Keysight Technologies Inc for 56 Days and Stryker Corporation for 21 Days on average.
| KEYS | SYK | |
|---|---|---|
Market Cap | $63.79B | $106.24B |
Volume | 1,435,384 | 2,982,001 |
Sector | Technology | Health |
52-Week High | $387.90 | $388.35 |
52-Week Low | $159.49 | $269.75 |
Typical Hold Time | 56 Days | 21 Days |
Enterprise Value | $63.93B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Keysight Technologies (KEYS) trades at $374.66, down 1.79% on the day, with strong technical momentum indicated by bullish moving averages and a consensus price target of $416.63 representing 11.2% upside. The company demonstrates robust fundamentals with Q2 2026 EPS of $3.07 beating expectations by 24%, supported by 56% order growth driven by AI infrastructure demand and 6G development opportunities. Revenue recovery to $5.38B in 2025 and net income margin expansion to 19.14% reflect improving operational efficiency.
KEYS presents compelling growth prospects from AI and 6G tailwinds, though elevated valuation multiples (P/E 50.7) and supply chain constraints pose near-term risks. Wall Street maintains strong bullish sentiment with 81% buy ratings, while technical indicators suggest the stock is testing key resistance at $375 with support at $370. The combination of accelerating earnings, strategic positioning in high-growth markets, and institutional confidence supports a positive medium-term outlook despite valuation concerns.
Stryker (SYK) trades at $276.97, up 0.57% today, amid a bearish technical signal with key support at $274 and resistance at $279. The company reported strong profitability with a 14.43% net income margin and beat Q2 2026 EPS estimates, though it missed in Q1. Recent news highlights ongoing legal scrutiny related to manufacturing issues disclosed in September 2026, which caused a significant share price drop.
Analyst consensus remains strongly bullish with a $368.11 price target, but risks include persistent manufacturing problems and potential securities litigation. Earnings growth and margin expansion support the long-term outlook, though near-term volatility may persist pending Q3 2026 results on October 29, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Keysight Technologies Inc
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
Read more on KEYS →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
